Velarion Records
Free. Unsubscribe any time.

Monopar Therapeutics (MNPR)

Monopar Therapeutics filed 5 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 3 reporting owners, covering 19 transactions and 14,465 shares. None carries the SEC's AFF10B5ONE flag; all 5 name a plan in a footnote. No results print is on file in this window, so no interval is measured.

What stands out

Trades in Monopar Therapeutics 19

Adoption dates in Monopar Therapeutics 0

Results prints in Monopar Therapeutics 0

Trades before a print in Monopar Therapeutics 0

Interval to Monopar Therapeutics’s next reported results date

How the interval and sources are counted →

Sources: SEC EDGAR full-text search and the SEC submissions API.